OPK R&D to Revenue
Opko Health Inc · R&D to Revenue
OPK R&D to Revenue
Latest reported20.28%period ending
OPK Quarterly R&D/Revenue (300.00% → 20.28%)
Latest values, visible window
High-resolution chart · PNG
OPK r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 20.2751% | |
| 23.5104% | |
| 22.0761% | |
| 19.8313% | |
| 19.3499% | |
| 20.5672% | |
| 16.5679% | |
| 16.5695% | |
| 13.2184% | |
| 12.6303% | |
| 10.6652% | |
| 10.8822% | |
| 6.8417% | |
| 13.724% | |
| 10.5363% | |
| 10.4549% | |
| 5.5677% | |
| 5.5623% | |
| 5.2343% | |
| 4.7448% | |
| 4.1188% | |
| 3.543% | |
| 3.5382% | |
| 4.3201% | |
| 5.8458% | |
| 10.2901% | |
| 10.2691% | |
| 13.1209% | |
| 12.4956% | |
| 16.6058% | |
| 15.0068% | |
| 12.4092% | |
| 11.078% | |
| 12.907% | |
| 17.6562% | |
| 12.2693% | |
| 10.5432% | |
| 8.9691% | |
| 10.0181% | |
| 8.397% | |
| 8.9653% | |
| 9.5596% | |
| 9.2245% | |
| 13.2395% | |
| 70.8501% | |
| 86.3216% | |
| 101.2824% | |
| 103.7627% | |
| 68.9488% | |
| 94.2534% | |
| 112.8455% | |
| 53.7038% | |
| 40.1201% | |
| 31.5847% | |
| 37.9435% | |
| 30.6994% | |
| 43.9722% | |
| 55.0416% | |
| 73.438% | |
| 48.4942% | |
| 32.131% | |
| 15.6547% | |
| 20.9077% | |
| 20.3053% | |
| 21.1268% | |
| 16.7634% | |
| 27.4221% | |
| 186.8754% | |
| 106.4337% | |
| 245.9365% | |
| 403.9123% | |
| 121.3086% | |
| 623.322% | |
| 154.2493% | |
| 453.3648% | |
| 0% | |
| 0% | |
| 2,891.4286% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 938.4615% | |
| 10,783.3333% | |
| 0% | |
| 564.8649% | |
| 372.6727% | |
| 363.0631% | |
| 332.1321% |